The planned facility, designated as the Translational Hub for THRIVE, will focus on the development, validation, and adoption of NAMs.
Changes in the political climate of the United States are spilling into scientific research. While many past administrations, of both parties, supported and funded science funding and education, the ...
Xylyx Bio, Inc., a regenerative medicine company developing bioengineered technologies for organ transplantation, tissue repair, and pharmaceutical drug development, today announced that the U.S. Food ...
Southern Research has landed an $8 million grant from the National Institutes of Health to build a national biomedical ...
Southern Research has been awarded an $8 million grant from the National Institutes of Health (NIH) to build the Translational Hub for Research, Innovation, Validation, and Excellence (THRIVE). This ...
Xylyx Bio has received U.S. Food and Drug Administration Orphan Drug Designation for Inspirex Lung and a $2.99 million ...
The hardest disease to care for when I was training as a pediatrician in the late 1970s was cystic fibrosis, a disease in which abnormally thick mucus secretions block the lungs’ airways and make it ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...